Table 1
Est.
Pt. No.
Age
& sex
1979
thyroid
dose
(rads)
(cont'd)
Thyroid Nodularities
Age at
detection
Surgery
Hypofunction
Diagnosis
TSH (uU/d1)
(c) Rongelap exposed at age >18
18 F
64 F
45
55
335
335
78 F
62
335
34 F
70
335
4M
63
71 F
52
66 F
55
335
34
41
Cleve. '69
Bost. '65
Papillary Ca
Papillary Ca
6.0,
335
335
7.0
6.6, 8.8
6.5, 7.0
55
Cleve.
'79
Adenomatous nod.
Cleve.
'72
Adenomatous nod.
6.3, 8.3
(d) Ailingnae exposed at age <10
8 F
53 F
—
26
33
450
320
18
28
Cleve.
(e) Ailingnae exposed at age 10-18:
‘81
Occult Pap. Ca
and adenomatous nod.
NONE
(f) Ailingnae exposed at age >18
51 F
50
45 F
57
41 M
135
135
59 F
69
--
135
16 M
64
135
135
45
Cleve.
51
Cleve.
53
Bost.
‘74
'73
'66
Adenoma
Adenomatous nod.
Nodule
Adenomatous nod.
(died '68, age 54)
6.4, 6.5
(g) Utirik exposed at age <10
2160 F
2154 F
3]
29
80
75
28
25
Cleve.
'75
2147 F
26
90
25
Cleve.
'79
2239 F
2132 F
28
27
80
80
28
27
Cleve.
'81
Cleve.
'81
Cleve.
'76
Papillary Ca
Nodule
reduced '79
Adenomatous nod.
"
"
"
"
(h) Utirik exposed at age 10-18
2229 F
2150 M
43
37
54
31
32
33
Cleve.
2236 M
36
55
34
Hono.
'69
'78
- 126 -
Adenoma
Papillary Ca
vs. atypical adenoma
Adenoma